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doi:10.1016/j.ejvs.2008.01.014Abstract Objectives: Fractalkine (CX3CL1) promotes adhesion and extravasation of leuco-
cytes through interactions with fractalkine receptor (CX3CR1) expressed on CD56þ/CD16þ
NK cells and CD8þ T cells. The current study aims to test the hypothesis the CX3CL1eCX3CR1
interaction contributes to the inflammatory infiltrate in AAA tissue.
Design and methods: Immunohistochemistry (IHC) was used to define expression of CX3CR1 in
AAA tissue. Multi-parametric flow cytometry (FC) was used to determine CX3CR1 expression on
T-cells (CD3þ) and NK cells (CD56þ) from AAA tissue and peripheral blood of AAA patients and
healthy controls. Regulation of CX3CL1 expression by vascular endothelial (vEC) and smooth
muscle cells (vSMC) was examined in vitro using primary cell cultures.
Results: CX3CR1þ cells were detected in 19/28 AAA tissue samples and predominately loca-
lised in the adventitia. PBMCs from patients with AAA demonstrated higher percentages of
CX3CR1þ NK cells (60.0e88.6%) and T cells (7.5e39.4%) compared with healthy controls.
Furthermore, the frequency of CX3CR1þ NK cells (91%) and T cells (94%) in inflammatory
AAA tissue were higher than in atherosclerotic AAA tissue. The pro-inflammatory cytokine TNFa
increased expression of fractalkine by vSMC and vEC.
Conclusion: CX3CL1þ and CX3CR1þ cells are present in AAA disease and their interaction may
contribute to the recruitment of inflammatory cells seen in AAA tissue.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.R. Carding, Institute of Mo-
ity of Leeds, Leeds LS2 9JT,
113 343 1421.
ac.uk (S.R. Carding).
ty for Vascular Surgery. PublisheIntroduction
Abdominal aortic aneurysm (AAA) is a complex, multifac-
torial vascular disorder characterised by a localised dilation
of the aorta. The pathogenesis of aneurysm formation isd by Elsevier Ltd. All rights reserved.
Table 1 Patient demographics
Criteria AAA patients Control
patients
Number 43* 9
Median age, years (IQR) 74 (70e78) 67 (63e71)
Men, n (%) 40 (93) 6 (67)
Median AAA diameter,
cm (IQR)
6.1 (5.6e7.2) n/a
Median lymphocyte
number 106/ml (IQR)
4.1 (3.4e5.6) 5.0 (4.3e6.8)
Current or ex-smoker, n (%) 38 (88) 2 (22)
Hypertension, n (%) 29 (67) 1 (11)
Abbreviations: AAA, abdominal aortic aneurysm; IQR, interquar-
tile range.
* 2 patients with inflammatory AAA.
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tissue and well-organised smooth muscle cell layers may be
attributed to an inflammatory process.1,2 Our group has
previously demonstrated that the majority of haemato-
poietic cells within the cellular infiltrate are T cells (58.1
 5.3%) and B cells (41.1 5.7%), with NK cells and macro-
phages present in low amounts (7.3 2.5% and 2.1 1.4%
respectively).3 The process by which these cells migrate
into the AAA tissue remains unclear.
Chemokines, chemoattractant cytokines synthesised at
sites of inflammation, regulate leukocyte trafficking
through interactions with G protein-coupled receptors.4
Recent evidence suggests that the chemokine fractalkine
(CX3CL1) plays an important role in inflammatory vascular
disorders.5,6 Fractalkine is a unique chemokine with an
extracellular domain of 76 amino acids including a novel
CX3C conserved cysteine motif.7
Vascular endothelial cells (vECs) express membrane-
bound fractalkine in response to proinflammatory stimuli
including TNFa (tumour necrosis factor-a) and IFNg (in-
terferon-g).8 IFNg, recently described in the development
and propagation of AAA,9 has also been shown to induce
expression of fractalkine on cultured aortic smooth muscle
cells in vitro.10
Cell surface fractalkine promotes capture of leucocytes
through interactions with CX3CR1 expressed on CD16þ NK
cells, CD8þ Tcells and CD14þmonocytes.11 Additionally, frac-
talkine increases NK cell adhesion and cytotoxicity towards
endothelial cells.12 The resulting injury to the endothelial
barrier may further amplify the migration of leucocytes.
Previous animal13 and human studies5,6 have demon-
strated a reduction of atherosclerosis in mice following
targeted deletion of CX3CR1 and increased expression of
CX3CL1 and CX3CR1 in patients with coronary artery disease
(CAD). However, the expression of fractalkine and CX3CR1 in
patients with AAA has not previously been investigated.
Therefore the aim of the present study was to characterise
the expression of CX3CR1 by AAA tissue and peripheral blood
mononuclear cells (PBMCs) of patients with AAA.
Materials and Methods
Patients and samples
Forty three patients admitted for elective infra-renal AAA
repair were studied (Table 1). From these patients, samples
of AAA tissue (eleven) and peripheral blood (seventeen)
were taken specifically for this study and a further 17
archival AAA tissue samples were available for inclusion.
Patients with atherosclerotic AAA and two patients with
inflammatory AAA identified by highly elevated C-reactive
protein, grossly thickened AAA wall and appearance at
surgery were included. Patients with diabetes, those
receiving immunosuppressive drugs and patients with previ-
ous or concurrent malignant disease were excluded. Nine
age-matched control patients admitted to hospital for
minor surgical procedures were also studied. Control
patients had no history of cardiovascular disease or periph-
eral vascular disease and were not on statin medication. To
date there have been no reports of sex-related differences
in fractalkine and CX3CR1 expression. Local Research EthicsCommittee approval was obtained and all individuals gave
their informed consent.
Cell isolation
Tissue mononuclear cells (MNCs) were isolated from fresh
AAA sections as previously described.3 Briefly, biopsies
were cleaned by agitation in phosphate-buffered saline
(PBS), diced using a 35 mm tissue homogeniser (Medima-
chine, Dako, UK) and filtered through a 70 mm filter (Becton
Dickinson, UK). Viable PBMCs and tissue MNCs were isolated
by density gradient centrifugation using Ficol-Isopaque
(Axis-Shield, Norway). The viability of isolated cells,
assessed by trypan blue dye exclusion, was routinely >90%.
Stromal cell culture
Human vECs, vSMCs (saphenous vein) and aSMCs (AAA) were
cultured by a modification of previously described
methods.14,15 Briefly, segments of saphenous vein were
obtained from patients undergoing bypass surgery with no
evidence of AAA and used as a source of vECs and vSMCs.
vECs were isolated and incubated at 37 C with collegenase
(Worthington, Lorne Laboratories, UK) for 10 min followed
by washing in DMEM supplemented with 5% fetal calf serum
(FCS) (LabTech International, UK). The cell pellet was
resuspended in complete endothelial culture medium;
M199 (Sigma Aldrich, Dorset) supplemented with 20% FCS,
100 mg/mL penicillin, 100 mg/mL streptomycin, 15 mg/mL
ECGS, 1 mM pyruvate (Sigma Aldrich, Dorset), 2 mM L-Glu-
tamine, 20 mM HEPES (Invitrogen, UK) and 5 units/mL hep-
arin (Leo Laboratory, UK) and grown to confluence. SMCs
were prepared using explant technique. Vessel segments
were maintained in DMEM medium supplemented with 10%
FCS, 100 mg/mL penicillin, 100 mg/mL streptomycin, 2 mM
L-Glutamine at 37 C in a humidified incubator in 5% CO2
in air. After 4e5 weeks cells were passaged and grown to
confluence. All cells were used between passages 2 and 5.
Immunohistochemistry
3 1 cm section of fresh AAA tissue was sampled from the
anterior aortic wall immediately after clamping the neck
22 A. Patel et al.of the aneurysm and the common iliac vessels. Samples
were used for immunohistochemical analysis (nZ 31) and
isolation of MNCs (nZ 2). Formalin-fixed AAA tissue was
embedded in paraffin and sectioned (5 mm). A series of
experiments using tonsil tissue were performed to deter-
mine optimal antibody concentrations and incubation times
for the immunohistochemical detection of CX3CR1.16
Briefly, dewaxed and rehydrated sections were incubated
with 0.3% H2O2 for 10 min at 25 C to block endogenous per-
oxidase activity prior to antigen unmasking by microwaving
(950 watts power) in 0.01 M sodium citrate buffer (pH 6.0)
for 5 min followed by rapidly cooling on ice for 3 min.
Endogenous biotin was blocked using avidin biotin blocking
kit (Vector Laboratories, UK). All antibodies were diluted
using antibody buffer TNB (0.1 M Tris, 0.15 M NaCl pH
7.5). After blocking nonespecific binding with rabbit IgG
(1:100, Vector Laboratories, UK) sections were incubated
for 1 h at 25 C with a rabbit anti-CX3CR1 antiserum
(1:100, Abcam, UK) or rabbit serum (1:100, Dako, UK)
used as a negative control. Biotinylated anti-rabbit IgG
(1:100, Dako, UK) was applied for 30 min, followed by
horseradish peroxidase conjugated avidin-biotin complexes
(Vector Laboratories, UK). Immunodetection was per-
formed using the peroxidase substrate 3,30-diaminobenzi-
dine (Vector Laboratories, UK). Tissue sections were
counterstained with Harris haematoxylin, dehydrated
through ethanol and xylene, mounted and examined with
a Zeiss microscope (Carl Zeiss, UK). Images were captured
using AxioVision software (Carl Zeiss, UK). Five fields of
view from the media and advential areas were assessed
for positive CX3CR1 staining using a three-plus system16
with the presence of CX3CR1 staining in 4 or 5 fields of
view reported as high (þþþ), 2 or 3 fields of view reported
as medium (þþ) and 1 field of view reported as low (þ).
Antibody staining and flow cytometry
PBMCs and tissue MNCs were incubated for 1 h at 25 C with
saturating amounts of commercial monoclonal antibodies
conjugated to biotin or a fluorochrome: anti-CD45 (BD Bio-
sciences, UK), anti-CD3 (clone S4$1) (Caltag, USA), anti-
CD56 (clone C5.9) (Dako, UK), anti-CD34 (Caltag, USA),
anti-myosin (Sigma-Aldrich, Germany) and anti-CX3CR1
(Abcam, UK). Cells were washed and incubated for 30 min
at 25 C with: FITC-conjugated swine anti-goat IgG (Caltag,
USA), biotin-conjugated anti-mouse IgG (Dako, UK) or
biotin-conjugated anti-rabbit IgG (Dako, UK). Bound biotin-
lyated antibodies were visualised by incubating with
Streptavidin-FITC (1:100, Caltag, USA), Streptavidin-PE
(1:100, BD Biosciences, UK) or Streptavidin-AF 633 (1:100,
Molecular Probes, UK) for 30 min at 25 C. Cells were
washed and analysed on a FACSCalibur flow cytometer
with Cell Quest software (Becton Dickinson, UK) analysing
5000 electronic events for each sample. Electronic gating
of cell populations was used to exclude tissue and cell
debris.
Human recombinant TNFa was added to cultured vSMCs
(10 ng/ml) and vECs (100 ng/ml) for 12e16 h.10,17 After
trypsin detachment, non-stimulated and stimulated cells
were washed in PBS and incubated with goat anti-human
fractalkine antibody (1:25, R&D Systems, UK) or goat Ig
(1:25, Dako, UK) for 1 h. After washing cells were incubatedfor 30 min with FITC-conjugated swine anti-goat IgG (1:50,
Caltag, USA). vECs were also stained with antibodies to
human CD34 (1:50 Caltag, USA),18 for 1 h followed by incu-
bation with Streptavidin-PE (1:100, BD Biosciences, UK) for
30 min. Cells were then either analysed using flow cytome-
try (FC) or were fixed for 12e16 h in 100 ml 0.1% paraformal-
dehyde at 4 C for intracellular staining with anti-myosin
heavy chain antibody (1:10, Sigma-Aldrich, Germany).19
For the detection of human myosin heavy chain cells were
incubated with biotin conjugated anti-mouse IgG (1:25,
Dako UK) followed by Streptavidin-FITC (1:100, Caltag,
USA) and analysed using FC as described above.
Statistical analyses
All values are given as percentage median values with
interquartile ranges. The Mann-Whitney Test was per-
formed with SPSS for Windows 12.0 software with P< 0.05
considered statistically significant.
Results
Localisation of CX3CR1D cells in AAA tissue
AAA tissue samples collected for this study (eleven) and
archival AAA tissue samples (seventeen) were assessed by
immunohistochemistry. An inflammatory infiltrate was
present in the media and adventitia of all AAA’s. Fractal-
kine receptor positive (CX3CR1þ) cells were detected in 19
out of 28 AAA’s with the highest amount of staining demon-
strated in the adventitia (Fig. 1E). CX3CR1þ cells were
detected in the adventitia of sixteen samples, of which
four contained high numbers of CX3CR1þ cells (stained cells
present in 4 or 5 fields of view) and five contained fewer
CX3CR1þ cells (stained cells present in 2 or 3 fields of
view). Seven samples contained CX3CR1þ cells in the media
(Fig. 1F), with one sample containing positive cells in 2
fields of view. No staining was seen in AAA tissue stained
with control antibodies (Fig. 1AeD).
Distribution of CX3CR1D cells in the blood
of AAA patients and healthy controls
To quantify and determine the phenotype of cells express-
ing CX3CR1 flow cytometry of PBMCs was carried out using
anti-CX3CR1 antibodies in conjunction with antibodies that
identify haematopoetic cells (CD45), T cells (CD3) and NK
cells (CD56) among PBMCs from AAA patients (nZ 17) and
healthy controls (nZ 9). Availability of reagents deter-
mined the number of samples stained. As previously
reported3 AAA patients had elevated numbers of peripheral
blood NK cells; 20.7% (13.9e27.2%) in AAA patients
compared to 15.7% (14.2e27.4%) in healthy controls.
A representative staining profile of PBMCs from an
individual AAA patient is shown in Fig. 2 with the distribution
of CX3CR1þ cells in PBMCs of all AAA patients and controls
shown in Fig. 3. The frequency of CX3CR1þ haematopoietic
cells was similar in patients with AAA (26.2, 23.7e28.7%)
and healthy controls (25.5, 19.3e27.8%), however AAA
patients demonstrated increased CX3CR1 expression among
NK cells and T cells. Patients with AAA had 77.1%
Figure 1 Localisation of fractalkine receptor (CX3CR1) in AAA. Adventitia and media stained with a control antibody (AeD) and
with anti-CX3CR1 antibody (E and F) with the arrows indicating representative CX3CR1þ cells. Images taken from 2 samples of AAA
tissue from a total of 28 AAA tissue samples analysed. Scale barZ 40 mm, Magnification 16 (A and B), 40 (CeD).
Fractalkine and Abdominal Aortic Aneurysm Disease 23(60.0e88.6%) of CD56þ NK cells expressing CX3CR1 com-
pared to 56.7% (50.4e73.1%) by CD56þ NK cells from control
patients. Furthermore, the percentage of CD3þ T cells
expressing CX3CR1 was 5.8% (1.7e13.6%) in healthy controls
and 13.2% (7.5e39.4%) in patients with AAA (Fig. 3).
Although the differences were not significant (p> 0.05),
there was an overall increased expression of CX3CR1 in
patients with AAA in comparison to healthy controls.
CX3CR1D cells in AAA tissue
Using flow cytometry we compared the distribution of
CX3CR1 expression among tissue mononuclear cells (MNCs)
isolated from single samples of atherosclerotic and in-
flammatory AAA tissue (Fig. 4). Virtually all (96%) CD45þ
haematopoietic MNCs from the inflammatory AAA tissue
sample expressed CX3CR1, whereas only 12% of the athero-
sclerotic AAA MNCs were CX3CR1þ (Fig. 4). In comparingexpression of CX3CR1 by CD3þ T cells and CD56þ NK cells
in the inflammatory AAA and atherosclerotic AAA infiltrate
it was clear that whereas the majority of T cells and NK
cells from inflammatory AAA expressed CX3CR1 only
a minority of these cells in atherosclerotic AAA were
CX3CR1þ (Fig. 4).
Regulation of fractalkine expression
by vSMCs and vECs
To further investigate expression of membrane-bound
fractalkine on SMCs and ECs, primary cultures of vSMCs,
vECs and aSMCs established from tissue explant cultures
were examined. TNFa, a pro-inflammatory stimulus dem-
onstrated in AAA tissue20 was used to stimulate expression
of fractalkine as previously described.10,17
FC analysis revealed increased expression of fractalkine
among all 3 cell types following exposure to TNFa (Fig. 5).
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Figure 2 Phenotype of CX3CR1þ PBMCs in atherosclerotic
AAA. PBMCs were stained with antibodies to CX3CR1, CD45,
CD3 and CD56, and analysed by flow cytometry. The four quad-
rants were set using isotype matched control antibodies and
the values shown represent the percentage of leucocytes in
each quadrant. Cells expressing CX3CR1 are shown in the upper
right hand quadrant with those lacking expression of CX3CR1
shown in the bottom right hand quadrant. The results shown
are representative of those obtained from 18 AAA patients
and 9 control subjects.
24 A. Patel et al.The greatest increase in CX3CR1 expression was seen in
vECs, increasing from 4.5% CX3CR1þ cells to 66.7% CX3CR1þ
following stimulation with TNFa. vSMCs and aSMCs
increased CX3CR1þ cells by 1.5 and 1.2 fold respectively
following stimulation with TNFa.25
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Figure 3 Distribution of CX3CR1þ PBMCs in patients with atherosc
subjects (nZ 7, 9, 9 for CD45, CD3 and CD56 respectively). Grey bo
and CD56 respectively). Box plot components are: horizontal line, m
circles, outliers.Discussion
This study is the first to investigate expression of fractal-
kine and CX3CR1 in AAA. We have identified CX3CR1þ cells
in the cellular infiltrate of AAA tissue as being predomi-
nately T cells and NK cells, with greater expression seen
in inflammatory AAA in comparison to atherosclerotic
AAA. Furthermore, primary vSMCs and vECs could be
induced to express fractalkine. Although this study is
limited by the sample size, our findings suggest expression
of fractalkine may be induced by inflammatory stimuli
and therefore may contribute to the pathogenesis of AAA
by mediating extravasation of leucocytes.
CX3CR1þ cells were present in both the media and
adventitia of AAA tissue to varying degrees. This may be
due to limitations of immunohistochemistry and specimens
taken at different stages of the disease process, however,
the results are consistent with CX3CR1 involvement in leu-
cocyte recruitment to aortic tissue. Traditionally, extrava-
sation of leucocytes has been described via the luminal
aspect of the vessel, however, recent studies have pro-
posed neovascularisation in aneurysmal tissue may permit
infiltration of leucocytes in AAA from the adventitia.2,21
Our findings of substantial infiltrate with evidence of angio-
genesis in both structural areas of AAA tissue supports this
theory.
Flow cytometry demonstrated considerable difference
in CX3CR1þ cells in inflammatory and atherosclerotic AAA
tissue, although the data was based on single samples.
Histologically, an inflammatory AAA is considered to be at
one extreme of a progressive continuum of increasing
inflammation involved in the pathogenesis of all AAAs.22
This extreme may be reflected in the high levels of
CX3CR1þ cells in the inflammatory AAA.
Animal and human studies favour the concept of a T-cell
mediated and IFNg triggered pathophysiological process in
AAA.9,23 Interaction between CD16þ peripheral blood
monocytes and CX3CL1þ endothelial cells results inCD3 CD56
lerotic AAA and healthy controls. White boxes represent control
xes represent AAA patient samples (nZ 2, 16, 17 for CD45, CD3
edian; box, interquartile range; whiskers, 5 and 95 percentiles;
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Figure 4 Phenotype of CX3CR1þ cells in atherosclerotic and inflammatory AAA. Tissue mononuclear cells were stained with
antibodies to CX3CR1, CD45, CD3 and CD56 and analysed by flow cytometry. Quadrants were set using isotype matched control
antibodies with numbers representing percentage cells positive in each quadrant. Cells expressing CX3CR1 are shown in the upper
right hand quadrant with those lacking expression of CX3CR1 shown in the bottom right hand quadrant. The results are from single
atherosclerotic and inflammatory AAA tissue samples.
Fractalkine and Abdominal Aortic Aneurysm Disease 25increased production of cytokines and the matrix metallo-
protease 9, a molecule associated with aneurysmal expan-
sion and rupture.24 Cells exhibiting other features of
cytolytic activity including intracellular perforin and
granzme B, have also been reported to show chemotaxis
towards soluble fractalkine and high expression of
CX3CR1.25 Additionally dendritic cells, described at the
adventitial level of the inflammatory infiltrate in AAA
express CX3CR1 mRNA and show chemotaxis towards frac-
talkine.26,27 This suggests fractalkine may contribute to
the pro-inflammatory state and the recruitment of leuco-
cytes reported in AAA tissue.
Among PBMCs, AAA patients demonstrated increased
CX3CR1þ cells in comparison to control subjects, although
the difference was not significant (p> 0.05). Potential con-
founding factors include smoking and hypertension, both of
which were significantly increased in AAA patients. These
risk factors for AAA can contribute to a pro-inflammatory
state28,29 potentially including an increased expression of
CX3CR1, which maybe further modified by anti-hyperten-
sive medication in the AAA patient group.5
CX3CR1 expression was most notable on CD56þ NK cells
in the peripheral blood and tissue of AAA patients.
Increased cytotoxicity and circulating levels of NK cells
have previously been described in AAA patients suggesting
NK cells have an important role in AAA disease.3,6 Yoneda
et al. reported fractalkine increased NK cell adhesion and
vEC susceptibility to NK cell mediated cytolysis.12 Our group
has previously shown that the NK cells present in AAA do not
secrete IFNg but have significant cytoxicity directed atvSMCs therefore fractalkine may affect the cytotoxity of
NK cells by increasing release of the lytic mediators
perforin and granzymes.3
The difference in CX3CR1 expressing cells in peripheral
blood and AAA tissue implies the role of the receptor may
vary between tissues. Studies of CX3CR1 expression in other
vascular inflammatory disorders have reported the majority
of CX3CR1þ cells were CD3þCD8þ T cells amongst PBMCs in
patients with CAD5 and SMCs in an atherosclerotic plaque6
suggesting the role of fractalkine and CX3CR1 expressing
cells maybe specific to the inflammatory disease and tissue.
Results from this ex-vivo study identify TNFa, a pro-
inflammatory stimuli demonstrated in AAA tissue,20 as
a stimulator of fractalkine expression on cultured ECs and
SMCs as previously shown.8,30 Stimulated aSMCs also dem-
onstrated fractalkine expression, however, the increase in
expression was much lower than that seen in non-diseased
vSMC. This may be due to maximum stimulation of cells
from AAA tissue in situ and as a result cells may be refrac-
tory to further inductive stimuli. Alternatively, aSMCs may
require the presence of other synergistic signals such as
pro-inflammatory cytokines for the expression of fractal-
kine.31 It is also important to note these results are based
on cells obtained from only a single AAA tissue sample
consequently there may be variability of fractalkine
expression as observed in previous experiments.16
The presence of fractalkine on vECs and CX3CR1þ cells in
both AAA tissue and PBMCs suggests fractalkine contributes
to the development of AAA disease. However, it is unclear
whether cells expressing fractalkine and CX3CR1 drive the
Ctrl. Ab
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Figure 5 Upregulation of fractalkine by vascular stromal
cells in response to TNFa. Primary cultures of vascular and aor-
tic smooth muscle cells (vSMC, aSMC) were incubated with 10
ng/ml TNFa for 12e16 h and vascular endothelial cells (vEC)
with 500 ng/ml TNFa for 12e16 h. The values shown represent
the proportion of cells expressing fractalkine following
stimulation.
26 A. Patel et al.formation of AAA or if initiation of AAA promotes expression
of fractalkine and CX3CR1. Current theories suggest an
antigenic stimulus e.g. damage to the vECs or presence of
elastin-derived peptides triggers the production of cyto-
kines in the aortic wall.32 vSMCs and ECs are activated by
this or an alternative stimuli e.g. infection with Chlamydia
pneumonia33 and increase production of membrane-bound
fractalkine promoting the extravasation and retention of
CX3CR1þ leucocytes into the aortic tissue. The high propor-
tion of CX3CR1þ NK cells suggests fractalkine-mediated
recruitment into AAA tissue contributes to the large popu-
lation of NK cells demonstrated in the cellular infiltrate of
AAA.3 Within the aneurysm tissue, fractalkine may promote
increased NK cell cytotoxicity causing damage to the struc-
ture of the aorta and therefore potentiating aneurysm
formation. Questions raised by this model centre around
the contribution fractalkine makes to the inflammatory
process of AAA. It is not known whether or not there is
a specific stimulus for vSMCs and vECs in AAA triggering
fractalkine expression or if fractalkine is the initiating
mediator for leucocyte recruitment. Importantly, theaffect of fractalkine on the function of inflammatory cells
and in particular NK cell cytoxicity in AAA disease remains
unclear.
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